Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC |
Karras Nolan E.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC |
Karras Nolan E.Director
|
SaleCommon Stock, No Par Value | 4,000 | $36.46 | $145,840.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.440 to $36.565, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 16, 2019 Filed Aug 20, 2019 23:22 UTC |
Karras Nolan E.Director
|
Exercise / conversionCommon Stock, No Par Value | 8,000 | $9.95 | $79,600.00 |
DisclosureSEC source: 0000856982-19-000117 · wf-form4_156634331321655.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 16, 2019 23:11 UTC |
Lampropoulos Fred P.Director · President & CEO
|
SaleCommon Stock, No Par Value | 40,000 | $36.86 | $1,474,480.00 |
DisclosureSEC source: 0000856982-19-000111 · wf-form4_156599707094808.xml · nonDerivative · entry 4 LAMPROPOULOS FRED P · CIK 0000901534 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,079,991 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.67 to $37.11, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · derivative · entry 6 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,246 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · derivative · entry 5 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,246 Underlying: Common Stock · 4,246 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 07/16/2016. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
Tax withholdingCommon Stock | 2,534 | $36.84 | $93,352.56 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 4 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,230 F2 · price: Stock options were exercised in a swap transaction with the Company. 2,534 shares of common stock were surrendered for payroll taxes and payment of the option price. None of such shares were sold in the open market. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock | 4,246 | $21.98 | $93,327.08 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
SaleCommon Stock | 3,780 | $36.67 | $138,616.38 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,518 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.67 to $36.69, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 23:03 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock | 5,000 | $18.80 | $94,000.00 |
DisclosureSEC source: 0000856982-19-000115 · wf-form4_156625579583030.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · derivative · entry 11 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2024-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. F5 · balance_after: Unvested stock options were forfeited and cancelled due to the reporting person's resignation as a director of the issuer. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · derivative · entry 10 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. F5 · balance_after: Unvested stock options were forfeited and cancelled due to the reporting person's resignation as a director of the issuer. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $20.27 | $0.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · derivative · entry 9 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016. F5 · balance_after: Unvested stock options were forfeited and cancelled due to the reporting person's resignation as a director of the issuer. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $13.99 | $0.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · derivative · entry 8 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · derivative · entry 7 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
SaleCommon Stock, No Par Value | 40,750 | $40.05 | $1,632,102.70 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 6 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,868 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.05 to $40.10, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 10,000 | $34.40 | $344,000.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 5 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $18.80 | $282,000.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 4 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $20.27 | $405,400.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 3 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $13.99 | $349,750.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 2 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 21:44 UTC |
STILLABOWER MICHAEL EDirector
|
Exercise / conversionCommon Stock, No Par Value | 25,000 | $9.95 | $248,750.00 |
DisclosureSEC source: 0000856982-19-000107 · wf-form4_156512784767641.xml · nonDerivative · entry 1 STILLABOWER MICHAEL E · CIK 0001192955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,618 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 20:20 UTC |
Frost RonaldChief Operating Officer
|
PurchaseCommon Stock | 5,000 | $40.00 | $200,000.00 |
DisclosureSEC source: 0000856982-19-000102 · wf-form4_156460443839706.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC |
Karras Nolan E.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 6,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 6,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC |
Karras Nolan E.Director
|
SaleCommon Stock, No Par Value | 4,000 | $60.91 | $243,640.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.815 to $60.980, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:22 UTC |
Karras Nolan E.Director
|
Exercise / conversionCommon Stock, No Par Value | 6,000 | $9.95 | $59,700.00 |
DisclosureSEC source: 0000856982-19-000095 · wf-form4_156106935965019.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:11 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $13.14 | $0.00 |
DisclosureSEC source: 0000856982-19-000093 · wf-form4_156106868209036.xml · derivative · entry 3 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2020-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 07/31/2014. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:11 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
SaleCommon Stock | 8,000 | $60.87 | $486,928.00 |
DisclosureSEC source: 0000856982-19-000093 · wf-form4_156106868209036.xml · nonDerivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.70 to $60.98, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 19, 2019 Filed Jun 20, 2019 22:11 UTC |
Lampropoulos Justin J.EVP GLOBAL SALES, MKTG & STGY
|
Exercise / conversionCommon Stock | 8,000 | $13.14 | $105,120.00 |
DisclosureSEC source: 0000856982-19-000093 · wf-form4_156106868209036.xml · nonDerivative · entry 1 Lampropoulos Justin J. · CIK 0001643609 · EVP GLOBAL SALES, MKTG & STGY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:54 UTC |
ANDERSON A SCOTTDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0001184825-19-000004 · wf-form4_155968165687878.xml · derivative · entry 9 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:46 UTC |
Miller Franklin JDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000087 · wf-form4_155968116241308.xml · derivative · entry 10 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:47 UTC |
LIU DAVID MING-TEHDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000088 · wf-form4_155968124452748.xml · derivative · entry 5 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:44 UTC |
Karras Nolan E.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000086 · wf-form4_155968106373213.xml · derivative · entry 11 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:39 UTC |
Gunderson Thomas J.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000085 · wf-form4_155968073635572.xml · derivative · entry 4 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:37 UTC |
STANGER KENT WDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000084 · wf-form4_155968064575616.xml · derivative · entry 11 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F10 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing on 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:35 UTC |
Millner F. Ann Ed.D.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000083 · wf-form4_155968049842499.xml · derivative · entry 7 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 31, 2019 Filed Jun 4, 2019 20:32 UTC |
Anderson JillDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 7,500 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000082 · wf-form4_155968034859600.xml · derivative · entry 4 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2026-05-31 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/31/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:07 UTC |
Gunderson Thomas J.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000066 · wf-form4_155917124890156.xml · derivative · entry 3 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:00 UTC |
Anderson JillDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000062 · wf-form4_155917084132513.xml · derivative · entry 2 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:04 UTC |
LIU DAVID MING-TEHDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000064 · wf-form4_155917105387030.xml · derivative · entry 4 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:14 UTC |
STANGER KENT WDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000067 · wf-form4_155917163932025.xml · derivative · entry 10 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F9 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:24 UTC Amendment |
Miller Franklin JDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000069 · wf-form4a_155917228234696.xml · derivative · entry 9 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F7 · derivative.exercise_price: Due to a clerical error, the reporting person is filing this Form 4/A to correct the exercise price of the derivative security reported on the initial Form 4 filed on May 29, 2019, from $53.95 to $52.17. F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:19 UTC |
ANDERSON A SCOTTDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0001184825-19-000002 · wf-form4_155917192829414.xml · derivative · entry 8 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:06 UTC |
Millner F. Ann Ed.D.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000065 · wf-form4_155917115138478.xml · derivative · entry 6 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 23:02 UTC |
Karras Nolan E.Director
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $52.17 | $0.00 |
DisclosureSEC source: 0000856982-19-000063 · wf-form4_155917092025067.xml · derivative · entry 10 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F8 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 24, 2019 Filed May 29, 2019 21:47 UTC |
Miller Franklin JDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 13,750 | $0.00 Strike: $53.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000061 · wf-form4_155916644134573.xml · derivative · entry 9 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2026-05-24 F7 · derivative.exercise_date: Becomes exercisable in equal annual installments of 33% commencing 05/24/2020. Read SEC document |
| May 07, 2019 Filed May 9, 2019 18:08 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0000856982-19-000051 · wf-form4_155742528599534.xml · derivative · entry 7 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2024-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 04/14/2018. Read SEC document |
| May 07, 2019 Filed May 9, 2019 18:08 UTC |
Parra Raul Jr.Chief Financial Officer
|
SaleCommon Stock, No Par Value | 2,000 | $57.11 | $114,212.00 |
DisclosureSEC source: 0000856982-19-000051 · wf-form4_155742528599534.xml · nonDerivative · entry 3 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.85 to $57.29, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 07, 2019 Filed May 9, 2019 18:08 UTC |
Parra Raul Jr.Chief Financial Officer
|
Exercise / conversionCommon Stock, No Par Value | 2,000 | $28.20 | $56,400.00 |
DisclosureSEC source: 0000856982-19-000051 · wf-form4_155742528599534.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 23:01 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 12,228 | $61.05 | $746,507.17 |
DisclosureSEC source: 0000856982-19-000041 · wf-form4_155424606413761.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,087 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.50 to $61.58, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 22:59 UTC |
Miller Franklin JDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0000856982-19-000040 · wf-form4_155424596597165.xml · derivative · entry 4 Miller Franklin J · CIK 0001327767 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.